○Yuuto Akagi¹, Kojiro Takamoto¹, Sakamoto Jun-ichi¹, Satoyasu Ito¹, Eri Manabe², Masaharu Ishihara², Takeshi Tsujino¹ (1. Sch. Pharm., Hyogo University of Health Sciences, 2. Department of Cardiology, Hyogo College of Medicine)

○Yuriko Sakurai¹, Mika Naganuma¹, Yoshiyuki Inami¹ (1. Qol Co.,Ltd)

○Angelina Yukiko Staub¹, Yukio Suga¹, Yasuhiro Ikawa², Kiyotaka Tsubouchi³, Mikie Hashimoto³, Atsufumi Kawagishi³, Tsutomu Shimada³, Yoshimichi Sai³, Katsuji Nishimura⁴, Ryo Matsushita¹ (1. Faculty of Pharmacy, Kanazawa University, 2. Department of Pediatrics, Kanazawa University Hospital, 3. Department of Pharmacy, Kanazawa University Hospital, 4. Department of Psychiatry, Tokyo Women’s Medical University)

○Tasuku Yokoyama^1,2, Shigeru Yamauti³, Keishi Yamagata³, Yuta Kaneshiro³, Yumiko Urano³, Keiji Murata³, Yoshinori Asahara¹, Kagawa Yoshiyuki² (1. Pharm. shimada Mun. Hosp., 2. Grad. Sch. Pharm. Sci., Shizuoka Univ., 3. Neurosurg. Shimada. Mun. Hosp.)

○Shoko Yamashita^1,2, Masayuki Ohbayashi², Miki Takenaka², Noriko Kohyama², Tatsuya Kurihara², Tomiko Sunaga², Hisaaki Ishiguro³, Mari Kogo² (1. Pharmacy, New Tokyo hospital, 2. Showa Univ. Sch. Pharmacy, 3. Cardiology, New Tokyo hospital)

○Sekiko Uehara¹, Yuuka Rachi¹, Keita Hirai^1,2, Toshihiro Shirai³, Kunihiko Itoh^1,2 (1. University of Shizuoka, 2. Shizuoka General Hospital, 3. Shizuoka General Hospital, respiratory)

○Ryota Jin¹, Akihiro Hisaka¹ (1. Grad. Sch. Parm. Sci., Chiba Univ.)

○Ami Yoshida¹, Mitsuhiro Goda², Masaya Kanda², Takahiro Niimura¹, Yuki Izawa-Ishizawa³, Masayuki Chuma⁴, Kenshi Takechi⁴, Kenji Ikuta², Yoshito Zamami^1,2, Keisuke Ishizawa^1,2 (1. Dept. Clin. Pharmacol. Ther.,Grad. Sch. Biomed. Sci., Tokushima Univ., 2. Dept. Pharm., Tokushima Univ. Hosp., 3. AWA Support Ctr., Toushima Univ., 4. Clin. Trial Ctr. Developmental Therap.,Tokushima Univ. Hosp.)

○Kiko Ishida¹, Hisao Haniu², Tamotsu Tsukahara³, Takeshi Uemura², Kazusaburo Sato⁴, Ken-ichi Sako¹, Toshio Inoue¹, Yoshikazu Matsuda¹ (1. Division of Clinical Pharmacology & Pharmaceutics, Nihon Pharmaceutical University, 2. Institute for Biomedical Sciences, Interdisciplinary Cluster for Cutting Edge Research, Shinshu University, 3. Department of Pharmacology and Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, 4. Sugar Lady Cosmetics Co., Ltd)

○Akira Yamagami¹, Masaki Kobayashi^1,2, Takehiro Yamada³, Yoshimasa Kitagawa⁴, Yoichi Ohiro⁴, Jun Sato^4,5, Nobuhisa Ishiguro⁵, Shungo Imai^1,2, Yo Takekuma^1,2, Mitsuru Sugawara^1,2, Ken Iseki^1,2 (1. Dept. Pharm., Hokkaido Univ Hosp., 2. Fac. Pharm. Sci., Hokkaido Univ. , 3. Fac. Pharm. Sci., Hokkaido Univ Sci., 4. Grad. Sch. Dent. Med., Hokkaido Univ., 5. Div. Infect. Cont. Prev., Hokkaido Univ Hosp.)

○Yuri Sasamoto¹, Yosuke Suzuki¹, Chisato Yoshijima¹, Ryota Tanaka², Hiroyuki Ono², Toshitaka Shin³, Hiromitsu Mimata³, Hiroki Itoh², Keiko Ohno¹ (1. Meiji Pharm. Univ., 2. Department of Clinical Pharmacy, Oita Univ. Hospital, 3. Department of Urology, Oita Univ. Faculty of Medicine)

○Michiko Sato¹, Yosuke Suzuki¹, Takuya Awazuhara¹, Tomoka Terashima¹, Keita Watanabe¹, Yusuke Nukui¹, Airi Yoshida¹, Rumi Fujioka², Katsuya Tsuchihara², Kunihiro Matsumoto¹, Keiko Ohno¹ (1. Meiji Pharm. Univ., 2. National Cancer Center)

○June Kosuda¹, Yosuke Suzuki¹, Banri Sato¹, Ayaka Fujii¹, Jun Negami¹, Keiko Ohno¹ (1. Meiji Pharm. Univ.)